Tilray CEO on shares being down, oversupply, U.S. cannabis regulations and Canada expansion plans

Tilray CEO on shares being down, oversupply, U.S. cannabis regulations and Canada expansion plans

Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to focus on about the company’s shares being down at some level of the last 12 months and what headwinds the company is…

Tilray CEO: Alternatives in clinical cannabis are super

Tilray CEO: Alternatives in clinical cannabis are super

Tilray’s stock is up on the present time, nonetheless level-headed down 80 p.c from a February high. CNBC’s Frank Holland reports on his conversation with Tilray CEO Irwin Simon in…